Related Experiment Video
Updated: Jan 24, 2026

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
Published on: April 29, 2017
Novel Myocardial PET/CT Receptor Imaging and Potential Therapeutic Targets
Ines Valenta1, Pal Pacher2, Vasken Dilsizian3
1Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University School of Medicine, Washington University in St. Louis, 510 S. Kingshighway Boulevard, Campus Box 8223, St. Louis, MO, 63110, USA.
Purpose Of The Review:
Activation of myocardial cannabinoid type 1 receptors (CB1-R) and/or angiotensin II type 1 receptors (AT1-R) likely plays an important mechanistic role in determining the left-ventricular remodeling process in systolic heart failure. We provide an overview on novel radiotracer probes and positron emission tomography (PET)/computed tomography (CT) imaging to noninvasively probe the expression of myocardial CB1-R and/or AT1-R.
Recent Findings:
Recent translational investigations have demonstrated the feasibility of 11C-OMAR or 11C-KR31173 and PET/CT to image and quantify myocardial CB1-R and/or AT1-R expression, respectively. There is an increasing understanding of the mechanisms of activated myocardial CB1-R and/or AT1-R to influence the left-ventricular remodeling process in systolic heart failure in different disease entities. The review summarizes contributions of PET to image myocardial CB1-R and AT1-R expression that may have the potential to serve as a target to tailor preventive medical care in the individual patient.
Insights
Novel imaging techniques using positron emission tomography (PET) can noninvasively assess cannabinoid type 1 receptors (CB1-R) and angiotensin II type 1 receptors (AT1-R) in heart failure. This aids in understanding left-ventricular remodeling and tailoring patient care.
Area of Science:
- Cardiovascular imaging
- Molecular imaging
- Radiochemistry
Background:
- Myocardial cannabinoid type 1 receptors (CB1-R) and angiotensin II type 1 receptors (AT1-R) activation are implicated in left-ventricular remodeling in systolic heart failure.
- Understanding these receptor expressions is crucial for developing targeted therapies.
Purpose of the Study:
- To review novel radiotracer probes and PET/CT imaging techniques for noninvasively assessing myocardial CB1-R and AT1-R expression.
- To highlight the role of these receptors in systolic heart failure and the potential of PET imaging.
Main Methods:
- Utilizing positron emission tomography (PET) combined with computed tomography (CT) for imaging.
- Employing specific radiotracer probes like 11C-OMAR for CB1-R and 11C-KR31173 for AT1-R.
Main Results:
- Demonstrated feasibility of PET/CT with 11C-OMAR and 11C-KR31173 to image and quantify myocardial CB1-R and AT1-R expression.
- Growing understanding of how activated CB1-R and AT1-R influence left-ventricular remodeling in various heart failure conditions.
Conclusions:
- PET imaging of myocardial CB1-R and AT1-R expression offers a noninvasive approach to assess heart failure mechanisms.
- This imaging modality holds potential for personalized preventive medical care in heart failure patients.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Internal Receptors
Therapeutic Index
Receptor-mediated Endocytosis